A large European study has raised new concerns about a widely used blood pressure medicine after researchers found that taking high doses of the drug may be linked to a greater risk of sudden cardiac arrest.
The study focused on nifedipine, a medicine that has been used for many years to treat high blood pressure and chest pain.
Scientists discovered that people taking high amounts of the drug appeared to face a higher risk of this deadly heart emergency compared to people taking lower doses or not taking the medicine at all.
The research was carried out by the European Sudden Cardiac Arrest network, a group that studies one of the most dangerous medical emergencies affecting people around the world. The findings were published in the European Heart Journal, one of the leading medical journals in heart research.
Sudden cardiac arrest is not the same as a heart attack, although many people confuse the two conditions. A heart attack happens when blood flow to part of the heart is blocked. Sudden cardiac arrest is different because the heart suddenly stops beating properly.
When this happens, blood can no longer reach the brain and other important organs. A person can collapse within seconds, stop breathing normally, and quickly lose consciousness. Without immediate treatment, death can happen within minutes.
Doctors usually try to save patients using CPR or a defibrillator, a device that sends an electric shock to restart the heart. Even with treatment, survival rates are often low.
Sudden cardiac arrest is one of the leading causes of death in Europe and many other parts of the world. Researchers estimate that it is responsible for about half of all deaths linked to heart disease.
The scientists in this new study wanted to better understand whether some commonly used heart medicines could affect the risk of sudden cardiac arrest. They focused on two medicines called nifedipine and amlodipine.
Both drugs belong to a group of medicines known as calcium channel blockers. These medicines work by relaxing blood vessels, making it easier for blood to flow through the body. This helps lower blood pressure and reduces strain on the heart.
Millions of people worldwide take these drugs every day. Doctors often prescribe them because they are effective and have been considered safe for a long time. Because the medicines are so common, any possible safety issue is important to investigate carefully.
To carry out the research, scientists examined medical records from thousands of people. They compared people who experienced sudden cardiac arrest with people who did not.
After carefully analyzing the information, the researchers noticed a surprising pattern. People who were taking high doses of nifedipine appeared more likely to suffer sudden cardiac arrest. The risk seemed to increase as the dose became higher.
What surprised researchers most was that the same problem was not found with amlodipine, even though the two medicines are very similar and are often used to treat the same conditions. Scientists say this unexpected difference needs further investigation.
The study does not prove that nifedipine directly causes sudden cardiac arrest. Instead, it shows a possible connection that needs more research. Medical studies sometimes discover links between a medicine and a health problem without proving that one directly causes the other. Other hidden factors may also play a role.
Researchers say one reason this risk may not have been discovered earlier is because sudden cardiac arrest happens very quickly and often without warning. Many patients die before doctors can fully investigate what triggered the event. This makes the condition especially difficult to study.
Even so, the findings are important because nifedipine has been prescribed for decades. The study shows why scientists continue to re-examine older medicines as medical technology improves and more health data becomes available.
A medicine that appears safe for many years can still reveal new risks when studied in larger groups of people over time.
Health experts are strongly warning patients not to stop taking nifedipine suddenly without medical advice. Suddenly stopping blood pressure medicine can itself be dangerous because blood pressure may rise quickly and increase the risk of heart problems or stroke.
Instead, patients who are concerned should speak with their doctor. Doctors may decide to review the dose, consider other treatment choices, or monitor heart health more closely. Patients who already have heart disease or other serious medical problems may need extra attention.
Researchers also remind people to watch for possible warning signs of heart trouble. Symptoms such as chest pain, severe shortness of breath, dizziness, fainting, or feeling extremely unwell should never be ignored. Anyone experiencing these symptoms should seek medical help immediately.
The study may also influence how doctors prescribe these medicines in the future. Some doctors may become more cautious about using very high doses of nifedipine if other treatment options are available.
Lower doses or different medicines such as amlodipine may sometimes be considered safer choices, although treatment decisions depend on each patient’s individual health condition.
Scientists say more studies are now needed to confirm the findings and understand why nifedipine may affect the heart differently from amlodipine. Future research may also help identify which patients are most at risk.
The findings are a reminder that medicine is always evolving. Doctors and researchers continue learning more about how medicines affect the body, even after those medicines have been used for many years. Ongoing research plays an important role in helping patients stay safe and receive the best possible treatment.
If you care about heart health, please read studies about top foods to love for a stronger heart, and why oranges may help fight obesity, diabetes, and heart disease.
For more health information, please see recent studies about simple guide to a 7-day diabetes meal plan, and why you should add black beans to your plate.
Copyright © 2026 Knowridge Science Report. All rights reserved.
